Fetal growth restriction
Also known as: FGR, Intrauterine growth restriction, IUGR, Pathological fetal growth restriction
Fetal growth restriction (FGR) denotes a failure to achieve biological fetal growth potential, distinct from a constitutionally small fetus. Placental dysfunction, maternal disease, and fetal conditions may contribute. Clinical management requires obstetric assessment, serial ultrasound growth and Doppler surveillance, and individualised decisions regarding delivery timing. The role of Chinese medicine is limited to adjunctive maternal symptomatic support alongside primary obstetric care; it cannot restore placental function or increase fetal growth. the cited evidence includes mouse and cell studies, a PCOS bibliometric analysis, and an observational pregnancy-loss cohort; none demonstrates acupuncture or herbal efficacy for FGR. The traditional patterns serve as educational frameworks, not diagnostic substitutes or pregnancy treatment protocols.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Attend all scheduled obstetric consultations, growth-scan, and Doppler appointments; request a written monitoring and escalation plan.
- •Maintain a diverse nutritional intake and adhere to prescribed antenatal supplementation; avoid supplementary copper based on current laboratory data.
- •Cease all tobacco use, vaping, alcohol consumption, and recreational drug use; utilise professional cessation services where required.
- •Balance gentle physical activity with rest according to obstetric guidance; do not employ prolonged bed rest, thermotherapy, or cold-avoidance as therapeutic interventions for FGR.
Cautions & Contraindications
- •Defer acupuncture or herbal treatment when preeclampsia symptoms or maternal instability are suspected and arrange urgent obstetric assessment. The supplied preeclampsia study is preclinical and does not establish acupuncture safety or these triage rules.[]
- •Do not stop aspirin, heparin or other prescribed treatment to facilitate adjunctive care. Antithrombotic use requires bleeding-risk review before needling and herbal consideration. Reference 4 describes treatment exposure in an observational cohort, not evidence for these procedural precautions or a regimen for FGR.[]
- •Do not prescribe copper or alter trace-element intake to treat FGR without medical assessment. The supplied copper-deficiency experiment used mice and cells and cannot establish supplementation benefit, dose or pregnancy safety in humans.[]
When to reassess or seek care again
Obstetric surveillance intervals take priority and must not be extended because maternal symptoms improve. If adjunctive symptom care is agreed, review within 7 days or after 1–2 sessions using a 0–10 target-symptom score, sleep duration, food tolerance and adverse effects. Track scan and Doppler findings only through the maternity team; subjective improvement does not indicate fetal improvement. Stop ineffective adjunctive care after two reviews. Any reduced movements, new hypertension symptoms or worsening obstetric findings require immediate maternity contact, not routine reassessment.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Life sciences · 2026
- Frontiers in medicine · 2026
- Biology of reproduction · 2026
- Frontiers in medicine · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
